Azathioprine (Imuran) for Dogs: Uses, Dosage & Side Effects

See your vet immediately if your dog on azathioprine develops pale gums, bruising, bleeding, vomiting that will not stop, black stools, fever, marked lethargy, or yellowing of the eyes or skin. These can be signs of serious medication complications or worsening immune-mediated disease.

Azathioprine is a prescription immunosuppressant that needs close veterinary supervision. It can affect the bone marrow, liver, pancreas, and infection risk, so home dosing should always match your vet's plan exactly.

This guide is educational and does not replace medical advice. Never start, stop, split, or taper azathioprine without talking with your vet, even if your dog seems better.

Azathioprine is an immunosuppressive medication used in dogs with diseases caused by an overactive or misdirected immune system. In veterinary medicine, it is used off-label from the human drug. That is common in specialty and general practice, but it means dosing and monitoring need to be individualized by your vet.

The drug works by interfering with purine synthesis and DNA replication in rapidly dividing immune cells. In practical terms, that means it helps slow down the immune attack that is damaging your dog's own red blood cells, platelets, skin, intestines, or other tissues.

Azathioprine is often paired with prednisone or prednisolone early in treatment. Steroids act faster, while azathioprine usually takes a few weeks to show its full effect. Once the disease is more stable, your vet may use azathioprine as a steroid-sparing medication so steroid doses can sometimes be reduced more safely over time.

Azathioprine is most often used for immune-mediated diseases in dogs. Common examples include immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, pemphigus complex, some cases of inflammatory bowel disease or lymphocytic-plasmacytic colitis, and systemic lupus erythematosus.

Your vet may also consider it when a dog needs more than steroids alone, or when steroid side effects are becoming hard to manage. In that setting, azathioprine is not a quick rescue drug. It is a longer-acting option that may help maintain control while allowing a more gradual steroid taper.

Not every dog with an autoimmune condition is a good candidate. Breed, body size, liver values, current medications, infection risk, and how urgently the disease needs control all matter. Your vet may recommend a different immunosuppressant if faster action, different side-effect tradeoffs, or easier monitoring fits your dog's case better.

A commonly referenced starting dose in dogs is 2 mg/kg by mouth every 24 hours for about 2 weeks, or about 50 mg/m², followed by every-other-day dosing or another taper plan based on response and lab work. That said, there is no one-size-fits-all schedule. Your vet may start lower, taper more slowly, or choose a different protocol depending on the disease being treated and your dog's bloodwork.

Azathioprine can be given with or without food. If your dog gets nausea or vomiting, giving it with a meal may help. If a dose is missed, contact your vet or pharmacist for guidance rather than doubling the next dose.

Monitoring is a core part of treatment, not an optional add-on. Many dogs need a CBC and chemistry panel every 1 to 2 weeks early on, then every 1 to 2 months once stable, with additional checks if symptoms change. This helps your vet catch bone marrow suppression, liver injury, or other complications before they become severe.

The most important azathioprine risk in dogs is bone marrow suppression. This can lower white blood cells, red blood cells, and platelets, which may lead to infection, weakness, pale gums, bruising, or bleeding. Because this complication can develop before obvious symptoms appear, scheduled bloodwork matters as much as the medication itself.

Other important side effects include digestive upset, decreased appetite, vomiting, diarrhea, pancreatitis, and liver toxicity. Dogs on long-term immunosuppressive therapy may also be more vulnerable to infections.

Call your vet promptly if you notice lethargy, fever, poor appetite, vomiting, diarrhea, yellowing of the eyes or gums, unusual bruising, nosebleeds, dark or bloody stool, or any sudden decline. Azathioprine is generally avoided in cats because they are much more sensitive to severe bone marrow toxicity.

Azathioprine has several meaningful drug interactions, so your vet should review every prescription, supplement, and over-the-counter product your dog receives. One of the most important is allopurinol. When used together, azathioprine can build up in the body and sharply increase the risk of dangerous bone marrow suppression.

Other medications that may raise concern include ACE inhibitors, aminosalicylates, corticosteroids, trimethoprim-sulfa and other drugs that affect bone marrow, and additional immunosuppressants such as cyclosporine or mycophenolate. These combinations are sometimes used intentionally, but they require closer monitoring and a clear plan.

Before starting any new medication, even something that seems routine, ask your vet or pharmacist to check for interactions. That includes compounded products and supplements.

Usually yes. Azathioprine can often be given with food if your dog gets stomach upset, but follow your vet's exact dosing instructions.

There is no widely accepted breed chart for azathioprine the way there is for some other medications. What matters more is the disease being treated, your dog's size, liver values, concurrent drugs, and how bloodwork changes over time. If your dog belongs to a breed with higher rates of immune-mediated disease, that affects why azathioprine may be considered, not whether it is automatically the right choice.

Breed-specific dosing: No standard breed-specific azathioprine dose adjustment is established

Breed risk pattern: Use is driven more by the underlying immune-mediated disease than by breed alone

Large-breed consideration: Body surface area dosing may be considered in some dogs, especially larger patients